Contribution of Vaccines to Life-Course Event-Free Health

Slides:



Advertisements
Similar presentations
Trends in Hospital Quality and Hospital Prevention of Surgical Complications, Overall Composite for All Three Conditions Percent of patients.
Advertisements

Update on Pneumococcal Vaccines
Dr. George Nelson Public health doctor specializing in respiratory disease Centers for Disease Control and Prevention Pneumococcal Pneumonia and Pandemic.
Epidemiological evidence for a protective role for statins in Community Acquired Pneumonia British Thoracic Society Winter Meeting 2012, London Yana Vinogradova.
Beth Anne Kelley AU/AUM.  Influenza is a contagious respiratory illness caused by influenza viruses  People over the age of 65 have greater risks of.
Thank you for viewing this presentation. We would like to remind you that this material is the property of the author. It is provided to you by the ERS.
Varicella Vaccine Robyn Mauldin-McLeod.
Better Health. No Hassles. Prevention PAYS! It’s a FREE physical, It’s at work, and It’s $25.00 in your pocket.
Respiratory CONNECT meeting Dr Julius Cairn. Risk stratification in PE Clinical parameters – shock, JVP, S3 Imaging – CTPA, echo Biomarkers – Troponin,
Preventing Influenza: Mandatory Vaccines for all Hospital Care Givers and Patients Ashley Lundberg Sara Ido.
Visibility of Vaccination and How Do We Improve?
By: Sarah Lombardi Is the Influenza Vaccination in the Geriatric Population Needed?
What are the health benefits and risks associated with vaccinating your child and why is it so important ?
Cost-effectiveness of pneumococcal vaccination for older people: a study in five western European countries Ament A, Baltussen R, Duru G, Rigaud-Bully.
Pharmacy in Public Health: Levels of Disease Prevention Add course Date here.
Attaran D, Mashhad university of medical sciences.
ADULT IMMUNIZATION An Unexploited Opportunity for Prevention William Schaffner, MD Professor of Preventive Medicine Department of Health Policy Professor.
Immunisation. What you should know 2 The difference between immunisation and vaccination Benefits of immunisation National Immunisation Program Myths.
Vaccine Education Module: Vaccines Updated: February 2015
Health and wellness.
Table 1. Baseline Characteristics of the 36,636 Study Subjects
August 2013 Goal: Promote the importance
Table 1 Characteristics of study population, by pneumococcal vaccination status. From: Prior Pneumococcal Vaccination Is Associated with Reduced Death,
Influenza Immunization:
Lessons for care of specific infectious morbidities
Program Goals Overview of HIV Epidemic HIV and Communities of Color.
HEART DISEASE # 1 Killer 1 death every 34 seconds
Select Topics in Cardiovascular Medicine
Managing Complex Hypertension: What Every Physician Should Know
Introduction. Risk Communication With Patients: Your Guide to Resources and Recommendations.
Global Update on Varicella: Protecting Against an Old Enemy
Managing Hard-To-Treat Hypertension: What Every Physician Should Know
RISK R isk of Perinatal and Early Childhood Infection
Adult Immunization: Making the Most of Everyday Opportunities
A Comprehensive Strategy Toward the Patient With Rhinorrhea
Heart Failure Management Coordinated Care Approaches
Immunizing the Older Adult: Challenges and Opportunities
HBV Care Models: Community Collaborations for Best Practices
Immunization Against Varicella:
Precision Management of RA and Comorbidities
The State of Pneumococcal Disease Prevention
Pneumococcal Disease Prevention in Children: Issues in the Era of PCVs
Time to Take Gout Seriously
CV Risk Management in T2DM: What Did We Learn from ADA 2016?
Aspirin in Cardioprevention:
Atrial Fibrillation.
Tools to Address Adherence Issues in Patients With SIHD
Diabetes and Cardiovascular Disease Risk: The Hard Truth
Serogroup B Meningococcal Disease
Diabetes and Cardiovascular Disease Risk: The Hard Truth
Combining Efforts for Older Drivers: Licensing Agencies, Occupational Therapists, and Clinicians.
Aspirin and Cardioprevention in 2018
Innovative Strategies to Promote Adult Immunizations
Battling the Flu: Latest Advances in the Influenza Treatment Arsenal
Addressing Pneumococcal Disease in Latino Communities
Immunization Throughout the Life Course: What Is the Clinician's Role?
Updates From ACC.
Are We Making Progress in the Management of Huntington Disease?
Nutrition Empowerment For the Community, By The Community
Challenges in Adult Vaccination
CHAPTER 3: Social determinants of health
Healthy With HIV.
The Patient With Early Stage MF-CTCL
Nurse Practitioners: At the Forefront of HPV-Related Disease Prevention.
Illustrative Performance Improvement Targets
MS, Age, and Immune Function
Exploring the Use of Adeno-Associated Virus for Gene Therapy
The Expanding Role of Community Pharmacists in Identification of At-Risk Patients and Provision of Pneumococcal Vaccinations Ed Cohen, PharmD Immunization.
Provider Attitudes Regarding Varicella Vaccine Objective
Taking a Closer Look at Probiotic Efficacy
Presentation transcript:

Contribution of Vaccines to Life-Course Event-Free Health

Progress in Vaccination Strategies

Program Overview

Childhood and Adolescent Vaccination

Childhood Vaccines Prevent Many Deadly Diseases

We Can Still Make Improvements in Vaccination Strategy

Communication With Parents Is Key

Vaccination in Adolescents

Concluding Remarks

The Role of Vaccines in Adulthood

Health in Adulthood

Vaccinations Provide Protection Throughout Life

Failure to Vaccinate Can Have Unintended Consequences

Adult Deaths Caused by Vaccine-Preventable Diseases

Comorbid Conditions and Infectious Disease

Herpes Zoster in Adults

Influenza Vaccination in Adults

Pneumococcal Pneumonia Vaccination in Adults

Importance of Vaccination When Traveling

Vaccine-Preventable Diseases and Comorbidities

VPDs Can Be a Trigger for Serious CV Events

Individuals Susceptible to Influenza

Effect of Influenza Vaccination on Hospitalization Due to CVDs

Association of Influenza Vaccination and Outcome in Patients With Heart Failure

Vaccinations Benefit Patients With CVD

Incidence of Pneumonia in Older Adults

Cardiac Complications in Patients With CAP

Vaccination Recommendations

Conclusions

Program Conclusions

Concluding Remarks

Abbreviations